Yield10 Bioscience Inc. (NASDAQ:YTEN): Matthew Strobeck’s Birchview Capital filed an amended 13D.
You can check out Birchview Capital’s latest holdings and filings here.
Please follow Birchview Capital (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Birchview Capital or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Birchview Capital GP||350,536||0||350,536||0||350,536||4.1%|
Page 1 of 12 – SEC Filing
AND EXCHANGE COMMISSION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-l(a)
AND AMENDMENTS THERETO FILED PURSUANT
TO RULE 13d-2(a)
$0.01 PAR VALUE PER SHARE
Class of Securities)
c/o Birchview Capital
Pine Street, Suite D
and Telephone Number of Person Authorized to Receive Notices and Communications)
Event Which Requires Filing of This Statement)
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ¨
the following pages)
1 of 12 Pages)
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in
a prior cover page.
required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of
the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act.